Julien Pestel

Mr. Julien Pestel

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 October 2021 in Cells
Verified
Journal Article
Open access
PDF file
Assia EljaafariAssia Eljaafari
Assia Eljaafari
JPJulien Pestel
Julien Pestel
Brigitte Le Magueresse-BattistoniBrigitte Le Magueresse-Battistoni
Brigitte Le Magueresse-Battistoni
SCStéphanie Chanon
Stéphanie Chanon
JWJulia Watson
Julia Watson
HVHubert Vidal
Hubert Vidal
The PD-L1/PD-1 immune checkpoint axis is the strongest T cell exhaustion inducer. As immune dysfunction occurs during obesity, we analyzed the impact of obesity on PD-L1/PD-1 expression in white adipose tissue (WAT) in mice and in human white adipocytes. We found that PD-L1 was overexpressed in WAT of diet-induced obese mice and was associated with increased expression of PD-1 in visceral but not subcutaneous WAT. Human in vitro cocultures with adipose-tissue-derived mesenchymal stem cells (ASC) and mononuclear cells demonstrated that the presence of ASC harvested from obese WAT (i) enhanced PD-L1 expression as compared with ASC from lean WAT, (ii) decreased Th1 cell cytokine secretion, and (iii) resulted in decreased cytolytic activity towards adipocytes. Moreover, (iv) the implication of PD-L1 in obese ASC-mediated T cell dysfunction was demonstrated through PD-L1 blockade. Finally, (v) conditioned media gathered from these cocultures enhanced PD-L1 expression in freshly differentiated adipocytes, depending on IFNγ. Altogether, our results suggest that PD-L1 is overexpressed in the WAT of obese individuals during IFNγ secretion, leading to T cell dysfunction and notably reduced cytolytic activity. Such a mechanism could shed light on why adipose-tissue-infiltrating viruses, such as SARS-CoV-2, can worsen disease in obese individuals.

1 February 2020 in Cytokine
Verified
Journal Article
Closed access
JPJulien Pestel
Julien Pestel
MCMarwa Chehimi
Marwa Chehimi
MBMélanie Bonhomme
Mélanie Bonhomme
MRMaud Robert
Maud Robert
HVHubert Vidal
Hubert Vidal
Assia EljaafariAssia Eljaafari
Assia Eljaafari

8 March 2019 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
PDF file
MCMarwa Chehimi
Marwa Chehimi
RWRobert Ward
Robert Ward
JPJulien Pestel
Julien Pestel
MRMaud Robert
Maud Robert
SPSandra Pesenti
Sandra Pesenti
Assia EljaafariAssia Eljaafari
Assia Eljaafari

11 July 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
FBFerdinand Blangero
Ferdinand Blangero
JPJulien Pestel
Julien Pestel
Assia EljaafariAssia Eljaafari
Assia Eljaafari
SPSee Pdf
See Pdf
Notch signaling emerges as a driver of adipose tissue (AT) inflammation. Having previously shown that obese AT derived mesenchymal stem cells (Ob-ASC) promote Th17 and pathogenic Th17.1 cell polarization upon interaction with immune cells, here we identify DNER, predominantly expressed by Ob-ASC in human AT, as the preponderant NOTCH ligand upregulated upon Ob-ASC/immune cell interaction., and demonstrate its causal role in NOTCH1-driven pathogenic Th17.1 cell activation. Indeed, NOTCH1 pharmacological inhibition reversed the Ob-ASC-mediated skewing toward IL-17A/IFNγ double-secreting Th17.1 cells and blocked intranuclear translocation of its intra-cellular domain (NICD1) in T cells. Transcriptomic profiling of Ob-ASC/immune cell co-cultures confirmed DNER as the top-upregulated NOTCH ligand. Mechanistically, DNER silencing in Ob-ASC reduced IL-17A secretion, while gain-of-function experiments with recombinant Fc-DNER demonstrated a preferential skewing toward IL-17A and IFNg secretion, dependent on NOTCH1, whose activation was validated by NICD1 intra-nuclear translocation in the presence of Fc-DNER. STED microscopy further demonstrated DNER-NOTCH1 nanoscale proximity at the Ob-ASC/T cell interface. In vivo, Dner-deficient mice fed a hypercaloric diet were protected from weight gain, fat mass accretion, dyslipidemia, liver steatosis, and exhibited reduced AT macrophage and CD8+ T cell infiltration, with subcutaneous AT-specific downregulation of Il17a, Leptin, Notch1, its canonical ligands and targets. Ex-vivo Ob-ASC/splenocyte co-cultures confirmed that Ob-ASC drive preferential DNER-dependent Th17.1 activation via NICD1 translocation. Together, these findings establish DNER as a novel Ob-ASC expressed NOTCH1 ligand that orchestrates preferential pathogenic Th17.1 cell polarization and metabolic dysfunction in obesity, representing a promising therapeutic target.